Caricamento...
Mechanisms of Resistance to Immune Checkpoint Blockade
The recent development of effective immune checkpoint inhibition (ICI), first demonstrated in melanoma, has revolutionized cancer treatment. Monoclonal antibodies blocking the immune checkpoints cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) and programmed death 1 receptor (PD-1) have shown su...
Salvato in:
| Pubblicato in: | Am J Clin Dermatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358473/ https://ncbi.nlm.nih.gov/pubmed/30259383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0389-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|